课题基金 / 基金详情

The role of N K T Cells in Transplantation

The role of N K T Cells in Transplantation
NK T 细胞在移植中的作用
批准号:
13671669
负责人:
YOSHIMURA Rikio
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

YOSHIMURA Rikio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Natural killer T cells in this model were shown to induce accelerated rejection. This effect could be specific for the NK cells or would be the results of a cooperation between the NK cells (secretion of cytokines) and T cells (as allocytotoxic effectors). From our study, not only T cells but also NK cells may play a role in organ transplantation rejection. NK-T cells may induce immune tolerance in organ transplantation. However, this mechanism using specific immune therapy for the induction of tolerance or to increase anti-cancer cytotoxic activity needs further study. These data confirm the inhibitory role of host NK cells in stem cell allogeneic engraftment. We have demonstrated the beneficial effect of anti-NK treatment. Treatment with anti-asialo-GM1 provides a means for improving the immunologjc conditioning of the recipient and showed no harmful effects. NK-cell activity was actually restored a few week after a brief inhibition, which may contribute strongly to maintaining a stable chimerism. Our data are comparable to those obtained with a lethally irradiated model reconstituted by more important semi-allogeneic FLCT mixed with a mature T-cell donor-which became activated and released cytokines. CD3^+ /CD56^+ cells, low in freshly isolated UCB, proliferated significantly in bulk MLC and represented a majority of the responders after single cell cloning. These cells expressed the CD8^+ phenotype and a few N-specific cells proliferated and exhibited an MHC-restricted killing activity. Cytokine production on the UCB clones was lower than in the PB clones, despite their stronger killing activity. The CD3^+ CD8^+ T cells, expressing, the CD56^+ marker, could be the major cells responsible for title induction of GVHD. They should be proven in HLA-mismatched UCB transplantation.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Chargui J, Ohyama A, Yoshimura R, Wada S, Hase T, Kishimoto T: "The inhibition of the NK cell activity induce improvement and stable chimerism after allogenic transplantation"Transpl Proc. 32(7). 2462-2463 (2000)
Chargui J、Ohyama A、Yoshimura R、Wada S、Hase T、Kishimoto T:“NK 细胞活性的抑制可在同种异体移植后诱导改善和稳定的嵌合状态”Transpl Proc。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Chargui J, Hase T, Wada S, Naganuma T, Yoshimura R: "NKT cells as non specific immuno-regulator inducing tolerance in mouse model transplantation"Transpl Proc. 33(7,8). 3833-3834 (2001)
Chargui J、Hase T、Wada S、Naganuma T、Yoshimura R:“NKT 细胞作为非特异性免疫调节剂在小鼠模型移植中诱导耐受”Transpl Proc。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hase T, Yoshimura R, Wada S, Chargui J: "Dentric cells, generated in vitro, are immunocompetent and very useful in the induction of specific CTL activity"Transpl Proc. 33(7,8). 3814-3815 (2001)
Hase T、Yoshimura R、Wada S、Chargui J:“体外产生的树突状细胞具有免疫活性,并且在诱导特定 CTL 活性方面​​非常有用”Transpl Proc。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Hase, R.Yoshimura, S.Wada, J.Chargui: "Dentric cells, generated in vitro, are immunocompetent and very useful in the induction specific CTL activity"Transpl.Proc.. 33(7-8). 3814-3815 (2001)
T.Hase、R.Yoshimura、S.Wada、J.Chargui:“体外产生的树突状细胞具有免疫活性,并且在诱导特异性 CTL 活性中非常有用”Transpl.Proc.. 33(7-8)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    The expression of Nonmuscle Myosin Heavy Chain B (SMemb) in Rat Allogeneic Kidney Transplantation Models
    • 批准号:
      11671574
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $0.77万
    • 财政年份:
      1999
    • 负责人:
      YOSHIMURA Rikio
    • 依托单位:
    Induction of hyperacute rejection of skin allografts by CD_8^+ Lymphoats
    • 批准号:
      09671642
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.22万
    • 财政年份:
      1997
    • 负责人:
      YOSHIMURA Rikio
    • 依托单位:
    国内基金
    海外基金
    SFRT激活新型STING调控因子协同CD3/CD20双抗治疗RR DLBCL的机制研究
    • 批准号:
      JCZRLH202600672
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    吸入式LNP靶向递送编码CD3/EGFR双特异性抗体的mRNA在肺癌治疗中的应用研究
    编码CLDN6/CD3双特异性抗体的膜脂复合物仿生递送系统增强实体瘤免疫治疗
    BTK调控肿瘤相关巨噬细胞在CD19/CD3双特异性抗体耐药中的研究
    • 批准号:
      82300214
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      于慧
    • 依托单位: